Does a rapid PSA increase suggest cancer spread?

Question

Hello doctor,

I am a 68-year-old male with a rapidly rising PSA, which has increased from 6.2 to 15.6 ng/mL over the past six months. A recent prostate biopsy showed high-grade adenocarcinoma with a Gleason score of 4+4=8 in 8 out of 12 cores. MRI imaging revealed a large tumor with probable capsular extension, and a bone scan identified suspicious lesions in the ribs and spine. My PSA velocity is 12 ng/mL per year, testosterone levels are within normal range at 450 ng/dL, and my alkaline phosphatase is elevated at 180 U/L, raising concern for possible bone involvement.

I am also experiencing urinary frequency, a weak stream, and progressively worsening lower back pain. Given these findings, I am concerned that the cancer may have already metastasized to the bones. Additionally, I would like to understand more about the potential side effects of hormone therapy, specifically the likelihood of experiencing hot flashes, muscle loss, and increased risks of heart disease and osteoporosis over the long term. Please help.

Thank you.

Answer 1

Hi,

Welcome to icliniq.com.

I understand your concern.

Has the cancer likely spread to the bones?

Based on your clinical findings:

High-grade prostate cancer (Gleason score 4+4=8).
Rapidly rising PSA (from 6.2 to 15.6 ng/mL in six months).
MRI(magnetic resonance imaging) indicates probable extracapsular extension.
Bone scan showing suspicious lesions in the ribs and spine.
Elevated alkaline phosphatase (a possible indicator of bone involvement).
Symptoms include ongoing lower back pain.

These findings strongly point toward metastatic prostate cancer, most likely involving the bones. While a biopsy of the bone lesions would provide a definitive diagnosis, in clinical practice, your care team would typically treat this as metastatic disease based on the current evidence.

What is the primary treatment?

The foundation of treatment in this setting is androgen deprivation therapy (ADT), also known as hormone therapy, which lowers testosterone levels that fuel prostate cancer growth.

In cases of newly diagnosed, high-volume metastatic disease, ADT is often combined with newer androgen receptor–targeted agents to improve outcomes.

What side effects can be expected from hormone therapy?

Here are some common side effects and management strategies:

Hot flashes – Frequently occur, though they can be managed with medications if bothersome.
Muscle loss and weight gain – Due to reduced testosterone levels, resistance training and regular physical activity are beneficial.
Bone thinning (osteoporosis) – Risk increases with long-term ADT. Bone density monitoring (DEXA scans) and preventive treatments (e.g., calcium, vitamin D, bisphosphonates, or denosumab) are recommended.
Cardiovascular and metabolic risks – ADT can raise the risk of diabetes, high cholesterol, and heart disease. Ongoing monitoring and healthy lifestyle choices are essential.
Sexual side effects – Loss of libido and erectile dysfunction are common.

What should happen next?

Collaborate with your oncologist and/or urologist to finalize your treatment plan, including ADT and potentially additional systemic therapies.
Discuss early implementation of a bone-protective strategy (DEXA scan, calcium/vitamin D supplementation, and medications if indicated).
Talk with your doctor about cardiovascular risk, especially if you have preexisting conditions like high blood pressure, diabetes, or heart disease.
Begin or maintain a tailored exercise and nutrition plan focused on preserving muscle mass and bone health.

I hope this helps.

Kindly revert if there are any queries.

Thank you.